Opinion
Change in federal law is a threat to health equity
A seemingly minor provision in the federal Inflation Reduction Act enacted last year could make it harder for marginalized patients to access the medicines their doctors have prescribed. It could also prevent the future development of cutting-edge, convenient treatments for many diseases that disproportionately affect communities of color.